The HDAC inhibitor domatinostat induces type I interferon α in Merkel cell carcinoma by HES1 repression

J Cancer Res Clin Oncol. 2023 Sep;149(11):8267-8277. doi: 10.1007/s00432-023-04733-y. Epub 2023 Apr 18.

Abstract

Background: Class I selective histone deacetylase inhibitors (HDACi) have been previously demonstrated to not only increase major histocompatibility complex class I surface expression in Merkel cell carcinoma (MCC) cells by restoring the antigen processing and presentation machinery, but also exert anti-tumoral effect by inducing apoptosis. Both phenomena could be due to induction of type I interferons (IFN), as has been described for HDACi. However, the mechanism of IFN induction under HDACi is not fully understood because the expression of IFNs is regulated by both activating and inhibitory signaling pathways. Our own preliminary observations suggest that this may be caused by suppression of HES1.

Methods: The effect of the class I selective HDACi domatinostat and IFNα on cell viability and the apoptosis of MCPyV-positive (WaGa, MKL-1) and -negative (UM-MCC 34) MCC cell lines, as well as, primary fibroblasts were assessed by colorimetric methods or measuring mitochondrial membrane potential and intracellular caspase-3/7, respectively. Next, the impact of domatinostat on IFNA and HES1 mRNA expression was measured by RT-qPCR; intracellular IFNα production was detected by flow cytometry. To confirm that the expression of IFNα induced by HDACi was due to the suppression of HES1, it was silenced by RNA interference and then mRNA expression of IFNA and IFN-stimulated genes was assessed.

Results: Our studies show that the previously reported reduction in viability of MCC cell lines after inhibition of HDAC by domatinostat is accompanied by an increase in IFNα expression, both of mRNA and at the protein level. We confirmed that treatment of MCC cells with external IFNα inhibited their proliferation and induced apoptosis. Re-analysis of existing single-cell RNA sequencing data indicated that induction of IFNα by domatinostat occurs through repression of HES1, a transcriptional inhibitor of IFNA; this was confirmed by RT-qPCR. Finally, siRNA-mediated silencing of HES1 in the MCC cell line WaGa not only increased mRNA expression of IFNA and IFN-stimulated genes but also decreased cell viability.

Conclusion: Our results demonstrate that the direct anti-tumor effect of HDACi domatinostat on MCC cells is at least in part mediated via decreased HES1 expression allowing the induction of IFNα, which in turn causes apoptosis.

Keywords: HES1; Histone deacetylase inhibitor; Interferon-stimulated genes; Interferons; Merkel cell carcinoma.

MeSH terms

  • Carcinoma, Merkel Cell* / drug therapy
  • Carcinoma, Merkel Cell* / genetics
  • Carcinoma, Merkel Cell* / metabolism
  • Cell Line, Tumor
  • Histone Deacetylase Inhibitors / pharmacology
  • Humans
  • Interferon Type I*
  • RNA, Messenger
  • Skin Neoplasms* / drug therapy
  • Skin Neoplasms* / genetics
  • Transcription Factor HES-1 / genetics

Substances

  • Histone Deacetylase Inhibitors
  • domatinostat
  • Interferon Type I
  • RNA, Messenger
  • HES1 protein, human
  • Transcription Factor HES-1